mRNA Bird Flu Vaccine Funding

This is a news story, published by NBC News, that relates primarily to * Department of Health and Human Services news.

News about vaccine development

For more vaccine development news, you can click here:

more vaccine development news

NBC News news

For more news from NBC News, you can click here:

more news from NBC News

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like this article about vaccine development, you might also like this article about

mRNA bird flu vaccine

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest bird flu vaccines news, bird flu vaccine news, news about vaccine development, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

broader bird flu vaccine

NBC News

•

As bird flu concerns grow, scientists race to develop new vaccines

Summary

Nutrition label

86% Informative

Department of Health and Human Services announces $590 million in funding to develop mRNA vaccine.

The money is in part to fast-track the development of an mRNA vaccine that targets the strains of bird flu currently circulating in wild birds, poultry and dairy cows.

The federal government already has two bird flu vaccine candidates in limited quantities in the nation’s stockpile.

Researchers are developing an adjuvant used in some vaccines that can generate a stronger immune response.

They hope to move from the preclinical stage to early-stage clinical trials in about a year .

A universal flu vaccine is scheduled to enter phase 1 clinical trials sometime in 2026 , but the urgency’ of H5N1 may move the trial date to sometime this year .

VR Score

Informative language

Neutral language

Article tone

semi-formal

Language

English

Language complexity

Offensive language

not offensive

Hate speech

not hateful